Combination therapy — pairing androgen deprivation therapy (ADT) with FDA-approved oral agents — has become a widely used ...

A cohort study of people who underwent fecal immunochemical (FIT) screening for colorectal cancer showed that interval cancer ...

Navigating a metastatic castration-resistant prostate cancer (mCRPC) diagnosis while preserving self-identity can feel like ...

In the past, having metastatic castrate-resistant prostate cancer was like a death sentence with clinician not having much ...

Paul Dennington, a dedicated fundraiser with terminal cancer, is embarking on a 588-mile "March Through Life" walking challenge across ...

Chicago Cubs great Ryne Sanberg faced prostate cancer with grace and openness. His goal was to help others. From the ...

New insights highlight how prostate cancer is now managed as a chronic disease, with emerging treatments and real-world data offering renewed hope for patients.

John Taylor, 69, from the Lake District, went to his GP twice complaining about needing to pass urine more than normal, but ...

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...